233 related articles for article (PubMed ID: 31180040)
21. Transcriptome sequencing identifies key pathways and genes involved in gastric adenocarcinoma.
Zhang W; Liu S; Zhan H; Yan Z; Zhang G
Mol Med Rep; 2018 Oct; 18(4):3673-3682. PubMed ID: 30106143
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
[TBL] [Abstract][Full Text] [Related]
23.
Zeng Y; He H; Zhang Y; Wang X; Yang L; An Z
Biomed Res Int; 2020; 2020():4612158. PubMed ID: 32685486
[TBL] [Abstract][Full Text] [Related]
24. Silencing of Long Noncoding RNA
Su W; Feng S; Chen X; Yang X; Mao R; Guo C; Wang Z; Thomas DG; Lin J; Reddy RM; Orringer MB; Chang AC; Yang Z; Beer DG; Chen G
Cancer Res; 2018 Jun; 78(12):3207-3219. PubMed ID: 29669758
[TBL] [Abstract][Full Text] [Related]
25. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
26. In silico analysis of overall survival with YBX1 in male and female solid tumours.
Grimes DR; Rassamegevanon T; Marignol L
Sci Rep; 2024 Mar; 14(1):7218. PubMed ID: 38538658
[TBL] [Abstract][Full Text] [Related]
27. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
Wang J; Tian Y; Chen H; Li H; Zheng S
Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
[TBL] [Abstract][Full Text] [Related]
28. Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells.
Jürchott K; Kuban RJ; Krech T; Blüthgen N; Stein U; Walther W; Friese C; Kiełbasa SM; Ungethüm U; Lund P; Knösel T; Kemmner W; Morkel M; Fritzmann J; Schlag PM; Birchmeier W; Krueger T; Sperling S; Sers C; Royer HD; Herzel H; Schäfer R
PLoS Genet; 2010 Dec; 6(12):e1001231. PubMed ID: 21170361
[TBL] [Abstract][Full Text] [Related]
29. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
31. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
[TBL] [Abstract][Full Text] [Related]
32. Mining topoisomerase isoforms in gastric cancer.
Hou G; Deng J; You X; Chen J; Jiang Y; Qian T; Bi Y; Song B; Xu Y; Yang X
Gene; 2020 Sep; 754():144859. PubMed ID: 32535049
[TBL] [Abstract][Full Text] [Related]
33. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
34. Pathway crosstalk analysis in prostate cancer based on protein-protein network data.
Li HY; Jin N; Han YP; Jin XF
Neoplasma; 2017; 64(1):22-31. PubMed ID: 27881001
[TBL] [Abstract][Full Text] [Related]
35. Bioinformatics approach reveals systematic mechanism underlying lung adenocarcinoma.
Wu X; Zhang W; Hu Y; Yi X
Tumori; 2015; 101(3):281-6. PubMed ID: 26045113
[TBL] [Abstract][Full Text] [Related]
36. Integrative analysis of cancer driver genes in prostate adenocarcinoma.
Zhao X; Lei Y; Li G; Cheng Y; Yang H; Xie L; Long H; Jiang R
Mol Med Rep; 2019 Apr; 19(4):2707-2715. PubMed ID: 30720096
[TBL] [Abstract][Full Text] [Related]
37. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
[TBL] [Abstract][Full Text] [Related]
38. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
39. TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.
Mullen DJ; Yan C; Kang DS; Zhou B; Borok Z; Marconett CN; Farnham PJ; Offringa IA; Rhie SK
PLoS Genet; 2020 Sep; 16(9):e1009023. PubMed ID: 32925947
[TBL] [Abstract][Full Text] [Related]
40. A novel circular RNA, circFAT1(e2), inhibits gastric cancer progression by targeting miR-548g in the cytoplasm and interacting with YBX1 in the nucleus.
Fang J; Hong H; Xue X; Zhu X; Jiang L; Qin M; Liang H; Gao L
Cancer Lett; 2019 Feb; 442():222-232. PubMed ID: 30419346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
